Domain Specificity of Anti-Prothrombin Antibodies That Express Lupus Anticoagulant Activity

被引：0
|
作者：
Gehlen, Rachel [1 ]
Noordermeer, Tessa [2 ]
Vandevelde, Arne [3 ,4 ]
Chayoua, Walid [1 ,5 ]
Ninivaggi, Marisa [6 ]
De Laat-Kremers, Romy [7 ]
Roest, Mark [8 ]
De Groot, Philip G. [1 ]
Devreese, Katrien M. J. [3 ,4 ]
Urbanus, Rolf T. [2 ]
De laat, Bas [6 ]
机构：
[1] Synapse Res Inst, Maastricht, Netherlands
[2] Univ Med Ctr Utrecht, Van Kreveldklin, Utrecht, Netherlands
[3] Ghent Univ Hosp, Coagulat Lab, Ghent, Belgium
[4] Univ Ghent, Dept Diag Sci, Ghent, Belgium
[5] Med Spectrum Twente, Enschede, Netherlands
[6] Synapse Res Inst, Dept Funct Coagulat, Maastricht, Netherlands
[7] Synapse Res Inst, Dept Data Anal & Artificial Intelligence, Maastricht, Netherlands
[8] Synapse Res Inst, Dept Platelet Pathophysiol, Maastricht, Netherlands
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185610
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?
    Galli, M
    JOURNAL OF AUTOIMMUNITY, 2000, 15 (02) : 101 - 105
  • [42] Quantification of lupus anticoagulants in clinical samples using anti-β2GP1 and anti-prothrombin monoclonal antibodies
    Le Querrec, A
    Arnout, J
    Arnoux, D
    Borg, JY
    Caron, C
    Darnige, L
    Delahousse, B
    Reber, G
    Sié, P
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 584 - 589
  • [43] Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism
    Zanon, E
    Saggiorato, G
    Ramon, R
    Girolami, A
    Pagnan, A
    Prandoni, P
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) : 255 - 258
  • [44] Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
    Egri, Natalia
    Bentow, Chelsea
    Rubio, Laura
    Norman, Gary L.
    Lopez-Sanudo, Susana
    Mahler, Michael
    Perez-Isidro, Albert
    Cervera, Ricard
    Vinas, Odette
    Espinosa, Gerard
    Ruiz-Ortiz, Estibaliz
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [45] Anti-phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all-comer population
    Pham, Michael
    Orsolini, Giovanni
    Crowson, Cynthia
    Snyder, Melissa
    Pruthi, Rajiv
    Moder, Kevin
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (09) : 2070 - 2074
  • [46] Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome
    Sciascia, Savino
    Sanna, Giovanni
    Murru, Veronica
    Roccatello, Dario
    Khamashta, Munther A.
    Bertolaccini, Maria Laura
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (02) : 354 - 364
  • [47] Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibodies are associated
    Sorice, H
    Pittoni, V
    Circella, A
    Misasi, R
    Conti, F
    Longo, A
    Pontieri, GM
    Valesini, G
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (04) : 713 - 715
  • [48] Association of lupus anticoagulant with transient antibodies to prothrombin in a patient with hypoprothrombinemia
    Amiral, J
    Aronis, S
    Adamtziki, E
    Garoufi, A
    Karpathios, T
    THROMBOSIS RESEARCH, 1997, 86 (01) : 73 - 78
  • [49] Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome
    Donohoe, S
    Mackie, IJ
    Isenberg, D
    Machin, SJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 544 - 549
  • [50] Anti-beta(2)-glycoprotein I and anti-prothrombin antibodies in haemodialysis patients
    Ducloux, D
    Florea, A
    Rebibou, JM
    Jamali, M
    Chalopin, JM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) : 2466 - 2467
12345